Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques - PubMed (original) (raw)
. 1998 Aug 15;248(1):95-107.
doi: 10.1006/viro.1998.9236.
Affiliations
- PMID: 9705259
- DOI: 10.1006/viro.1998.9236
Free article
Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques
J M Harouse et al. Virology. 1998.
Free article
Abstract
Infection of macaques with chimeric simian/human immunodeficiency virus (SHIV) expressing the envelope protein of HIV-1 provides a model system for studying HIV-1 infection in humans. To this end, four rhesus macaques (Macaca mulatta) were given a single intravaginal (IVAG) inoculation of cell-free SHIVSF33A and longitudinal samples of peripheral blood and lymph nodes were analyzed for viremia, antigenemia, and various T-cell populations. Rhesus macaques infected IVAG with SHIVSF33A demonstrated a dramatic decrease in the CD4(+) PBMC subset in the initial weeks after viral exposure, a time that corresponded to peak in plasma viremia and antigenemia. Within 4 months of SHIVSF33A inoculation, partial to complete rebound of the CD4(+) PBMC was seen in these animals. Notably, the regeneration of the CD4(+) subset was associated with regeneration of the naive T-cell population and was concordant with clearance of plasma viremia. DNA heteroduplex tracking assays revealed transmission of minor variants within the SHIVSF33A inoculum to the IVAG-inoculated animals. The cell-free SHIVSF33A inoculum as well as virus isolated from animals early after transmission used the chemokine molecule CXCR4 as the primary cellular coreceptor, demonstrating that viruses expressing envelope glycoproteins of the syncytia inducing (SI) phenotype can be transported across the vaginal mucosa. Although none of the animals has yet to develop clinical symptoms of simian AIDS (SAIDS), infectious virus and viral nucleic acids could be persistently isolated from each animal. Furthermore, animals transfused with blood from IVAG-infected macaques drawn 2 weeks after inoculation suffered a more profound and sustained CD4(+) T-cell loss, persistent plasma viremia, and the development of SAIDS in one animal, indicating that IVAG-passaged SHIVSF33A was pathogenic. Taken together, these results establish that a pathogenic CXCR4-utilizing SHIVSF33A species crossed the cervicovaginal mucosa. Different courses of infection in the IVAG versus transfusion animals suggest that host-mediated responses elicited upon transmission across mucosal barriers may serve to limit viral replication and delay disease progression in the IVAG-infected animals.
Copyright 1998 Academic Press.
Similar articles
- Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.
Luciw PA, Mandell CP, Himathongkham S, Li J, Low TA, Schmidt KA, Shaw KE, Cheng-Mayer C. Luciw PA, et al. Virology. 1999 Oct 10;263(1):112-27. doi: 10.1006/viro.1999.9908. Virology. 1999. PMID: 10544087 - Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
McCormick-Davis C, Zhao LJ, Mukherjee S, Leung K, Sheffer D, Joag SV, Narayan O, Stephens EB. McCormick-Davis C, et al. Virology. 1998 Sep 1;248(2):275-83. doi: 10.1006/viro.1998.9300. Virology. 1998. PMID: 9721236 - Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta.
Bogers WM, Dubbes R, ten Haaft P, Niphuis H, Cheng-Mayer C, Stahl-Hennig C, Hunsmann G, Kuwata T, Hayami M, Jones S, Ranjbar S, Almond N, Stott J, Rosenwirth B, Heeney JL. Bogers WM, et al. Virology. 1997 Sep 15;236(1):110-7. doi: 10.1006/viro.1997.8744. Virology. 1997. PMID: 9299623 - Nonhuman primate models for cell-associated simian immunodeficiency virus transmission: the need to better understand the complexity of HIV mucosal transmission.
Bernard-Stoecklin S, Gommet C, Cavarelli M, Le Grand R. Bernard-Stoecklin S, et al. J Infect Dis. 2014 Dec 15;210 Suppl 3:S660-6. doi: 10.1093/infdis/jiu536. J Infect Dis. 2014. PMID: 25414421 Review.
Cited by
- The selection of low envelope glycoprotein reactivity to soluble CD4 and cold during simian-human immunodeficiency virus infection of rhesus macaques.
McGee K, Haim H, Korioth-Schmitz B, Espy N, Javanbakht H, Letvin N, Sodroski J. McGee K, et al. J Virol. 2014 Jan;88(1):21-40. doi: 10.1128/JVI.01558-13. Epub 2013 Oct 16. J Virol. 2014. PMID: 24131720 Free PMC article. - Genetic similarity of circulating and small intestinal virus at the end stage of acute pathogenic simian-human immunodeficiency virus infection.
Matsuyama-Murata M, Inaba K, Horiuchi R, Fukazawa Y, Ibuki K, Hayami M, Miura T. Matsuyama-Murata M, et al. Front Microbiol. 2013 Jul 22;4:204. doi: 10.3389/fmicb.2013.00204. eCollection 2013. Front Microbiol. 2013. PMID: 23885255 Free PMC article. - Clinical significance of HIV-1 coreceptor usage.
Schuitemaker H, van 't Wout AB, Lusso P. Schuitemaker H, et al. J Transl Med. 2011 Jan 27;9 Suppl 1(Suppl 1):S5. doi: 10.1186/1479-5876-9-S1-S5. J Transl Med. 2011. PMID: 21284904 Free PMC article. Review. - Gaining a foothold: how HIV avoids innate immune recognition.
Yan N, Lieberman J. Yan N, et al. Curr Opin Immunol. 2011 Feb;23(1):21-8. doi: 10.1016/j.coi.2010.11.004. Epub 2010 Nov 29. Curr Opin Immunol. 2011. PMID: 21123040 Free PMC article. Review. - 3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1.
Li L, He L, Tan S, Guo X, Lu H, Qi Z, Pan C, An X, Jiang S, Liu S. Li L, et al. Antimicrob Agents Chemother. 2010 May;54(5):1700-11. doi: 10.1128/AAC.01046-09. Epub 2010 Mar 1. Antimicrob Agents Chemother. 2010. PMID: 20194691 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials